Our leadership is deeply embedded in the industry and supported by an Advisory Board of experts from every sector that we serve.
Staying at the cutting edge of every change in the market allows us to deliver the right candidates for your business and provide invaluable counsel no matter how unique your needs.
Founded in 2000, Slone Partners is a premier executive search firm that specializes in recruitment for companies focused in biotechnology, pharma services, life science tools, diagnostics, genomics, clinical services, medical devices, data and analytics, and food sciences.
The Conference Board’s latest measure of CEO confidence, which had increased in the first quarter of 2018, declined slightly in the second quarter. The measure now reads 63, down from 65 in the first quarter of 2018. A reading of more than 50 points reflects more positive than negative responses. “CEO Confidence declined slightly in the
Executive search firm Slone Partners has placed Bob Beechey as the new CFO of Vermillion Inc., a bio-analytical solutions company focused on gynecologic disease. “Bob is a brilliant financial mind whose experience managing the business and commercial aspects of healthcare companies will prove invaluable to Vermillion,” said Tara Kochis-Stach, president of Slone Partners. Mr. Beechey has served
To keep up with the mind-bending changes that are coursing through the life sciences sector, recruiters who specialize in this area are keeping an open mind to new possibilities in their own work. As Leslie Loveless, CEO of Slone Partners explains, the life sciences industry has become increasingly consumer-centric, opening the door for recruiting more
Executive search firm Slone Partners has placed Roger Moody as chief financial officer of Clinical Genomics. Mr. Moody will direct all strategic and tactical financial operations for the biotechnology business. His extensive experience in managing rapid growth and delivering for investors will be instrumental in achieving Clinical Genomics’ expansion objectives, the company said. “We are thrilled to
Thought Leadership
Elevating Executive Presence: A Blueprint for Life Sciences and Biotech Leaders
What’s Next in Precision Medicine: Leadership Challenges and Opportunities
Full-Time vs. Fractional Talent: What’s the Best Fit for Your Organization?
Fractional Talent On Demand: The Slone Partners Difference
Life Sciences Leadership, Redefined: What Boards are Looking for in 2025